| 000 | 01814 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516064328.0 | ||
| 264 | 0 | _c20120625 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1097-0290 | ||
| 024 | 7 |
_a10.1002/bit.24382 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHammers, David W | |
| 245 | 0 | 0 |
_aControlled release of IGF-I from a biodegradable matrix improves functional recovery of skeletal muscle from ischemia/reperfusion. _h[electronic resource] |
| 260 |
_bBiotechnology and bioengineering _cApr 2012 |
||
| 300 |
_a1051-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAbsorbable Implants |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 |
_aFibrin _xadministration & dosage |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 |
_aHindlimb _xblood supply |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xblood supply |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xphysiology |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTourniquets |
| 700 | 1 | _aSarathy, Apurva | |
| 700 | 1 | _aPham, Chantal B | |
| 700 | 1 | _aDrinnan, Charles T | |
| 700 | 1 | _aFarrar, Roger P | |
| 700 | 1 | _aSuggs, Laura J | |
| 773 | 0 |
_tBiotechnology and bioengineering _gvol. 109 _gno. 4 _gp. 1051-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/bit.24382 _zAvailable from publisher's website |
| 999 |
_c21322582 _d21322582 |
||